White & Case Guides PE Biz's $220M Swedish Pharma Buyout
Private equity firm EQT said Tuesday it has made a 2.23 billion Swedish kronor ($220 million) public cash offer for the remaining shares in Swedish biopharmaceuticals group Karo Pharma, in a...To view the full article, register now.
Already a subscriber? Click here to view full article